EcoR1 Capital, LLC 13D/13G Filings for Edgewise Therapeutics, Inc. (EWTX)

EcoR1 Capital, LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
6:22 pm
Sale
2024-09-3013GEdgewise Therapeutics, Inc.
EWTX
EcoR1 Capital, LLC1,250,385
1.300%
-2,242,809decrease
(-64.21%)
Filing
2022-09-26
4:06 pm
Purchase
2022-09-1413GEdgewise Therapeutics, Inc.
EWTX
EcoR1 Capital, LLC3,493,194
5.500%
3,493,194increase
(New Position)
Filing